Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Account Payables (2019 - 2025)

Korro Bio's Change in Account Payables history spans 7 years, with the latest figure at -$637000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 5.29% year-over-year to -$637000.0, compared with a TTM value of -$2.3 million through Dec 2025, down 72.33%, and an annual FY2025 reading of -$2.3 million, down 72.33% over the prior year.
  • Change in Account Payables for Q4 2025 was -$637000.0 at Korro Bio, up from -$2.9 million in the prior quarter.
  • The five-year high for Change in Account Payables was $2.8 million in Q4 2023, with the low at -$2.9 million in Q3 2025.
  • Average Change in Account Payables over 5 years is -$54450.0, with a median of -$215500.0 recorded in 2023.
  • Year-over-year, Change in Account Payables soared 1128.71% in 2024 and then tumbled 1152.4% in 2025.
  • Tracing KRRO's Change in Account Payables over 5 years: stood at -$382000.0 in 2021, then surged by 439.27% to $1.3 million in 2022, then skyrocketed by 115.35% to $2.8 million in 2023, then tumbled by 121.68% to -$605000.0 in 2024, then decreased by 5.29% to -$637000.0 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Change in Account Payables are -$637000.0 (Q4 2025), -$2.9 million (Q3 2025), and $1.1 million (Q2 2025).